Lipid TG4C

Lipid TG4C
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay42941-1 1 mg -

6 - 10 business days*

102.00€
Cay42941-5 5 mg -

6 - 10 business days*

381.00€
Cay42941-10 10 mg -

6 - 10 business days*

558.00€
 
Lipid TG4C is an ionizable cationic glycerolipid (pKa = 6.71) that has been used in the... more
Product information "Lipid TG4C"
Lipid TG4C is an ionizable cationic glycerolipid (pKa = 6.71) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo. LNPs containing lipid TG4C and encapsulating mRNA encoding human erythropoietin (EPO) increase serum EPO levels in mice. Nebulized administration of LNPs containing lipid TG4C and encapsulating mRNA encoding human hepatocyte growth factor (HGF) reduces bronchoalveolar lavage fluid (BALF) levels of Il-1beta, Il-6, and Tnf-alpha in a mouse model of pulmonary emphysema induced by porcine pancreatic elastase.. Solulibility: Ethanol: Soluble: =10 mg/ml: .
Keywords: hexanedioic acid, 1,1'-[2-[4-(dimethylamino)-1-oxobutoxy]-1,3-propanediyl] 6,6'-bis(1-octylnonyl) ester
Supplier: Cayman Chemical
Supplier-Nr: 42941

Properties

Application: Ionizable cationic glycerolipid, LNP formation
MW: 938.43 D
Formula: C55H103NO10
Purity: >95%
Format: Solution

Database Information

CAS : 3028336-07-1| Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H225, H319, H333
P Phrases: P210, P233, P240, P241, P242, P243, P264, P280, P303+361+353, P304+312, P305+351+338, P337+313, P370+378, P403+235, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Lipid TG4C"
Write a review
or to review a product.
Viewed